Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

588
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
588
Overview of the Cardiovascular System01:14

Overview of the Cardiovascular System

12.3K
The cardiovascular system is a vital transportation system in the body. It comprises the heart and blood vessels and facilitates the exchange of gases, nutrients, and waste products.
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
12.3K
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

4.2K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
4.2K
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

4.6K
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.6K
Assessment of the Cardiovascular System II: Inspection01:29

Assessment of the Cardiovascular System II: Inspection

925
Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck
925
Assessment of the Cardiovascular System IV: Auscultation01:25

Assessment of the Cardiovascular System IV: Auscultation

2.0K
Cardiac auscultation is a clinical skill used to assess heart function and detect abnormalities. It involves listening to heart sounds at specific anatomical locations through a stethoscope.
Normal Heart Sounds
S1 (First Heart Sound)-
S1 is made by the closure of the mitral and tricuspid valves (atrioventricular valves), marking the beginning of systole.
S2 (Second Heart Sound)-
S2 is made by the closure of the aortic and pulmonic valves (semilunar valves), marking the end of the systole.
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).

Sexual medicine reviews·2025
Same author

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening: Erratum.

The Journal of urology·2025
Same author

Relative Impact of Male Urinary Conditions on Overall Quality of Life.

Neurourology and urodynamics·2025
Same author

Downregulation of spermatogenesis-associated transcripts in the spermatozoa of idiopathic infertile men.

Andrology·2025
Same author

Testosterone deficiency and treatments: common misconceptions and practical guidance for patient care.

Sexual medicine reviews·2025
Same author

Editorial Comment on "Genitourinary Fellowship for Family Medicine Physicians".

Urology·2025

Related Experiment Video

Updated: Feb 15, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.1K

Erectile Dysfunction and Subclinical Cardiovascular Disease.

Martin Miner1, Sharon J Parish2, Kevin L Billups3

  • 1Men's Health Center, Miriam Hospital, Providence, RI, USA; Departments of Medicine and Urology, Warren Alpert School of Medicine, Brown University, Providence, RI, USA.

Sexual Medicine Reviews
|February 4, 2018
PubMed
Summary
This summary is machine-generated.

Erectile dysfunction (ED) is an early indicator of cardiovascular disease (CVD) risk. Early assessment and management of ED can help identify and reduce future cardiovascular events in men.

Keywords:
American College of Cardiology/American Heart Association Score for MenCardiovascular Risk StratificationCoronary Calcium ScoreErectile DysfunctionVasculogenic

More Related Videos

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.9K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Related Experiment Videos

Last Updated: Feb 15, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
04:22

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility

Published on: May 30, 2025

1.1K
Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
09:49

Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy

Published on: December 28, 2021

3.9K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K

Area of Science:

  • Cardiology
  • Urology
  • Men's Health

Background:

  • Erectile dysfunction (ED) is recognized as an independent marker for cardiovascular disease (CVD).
  • ED can indicate the presence of subclinical coronary artery disease (CAD) in asymptomatic men.

Purpose of the Study:

  • To explore ED as an early marker of subclinical CVD.
  • To propose an algorithm for evaluating and managing cardiovascular risk in men with vasculogenic ED.

Main Methods:

  • A comprehensive literature review and expert consensus were used to develop clinical recommendations.
  • The review incorporated original research and expert consensus documents on ED management and CV risk.

Main Results:

  • ED assessment can aid in identifying and mitigating future CVD risks.
  • Initial evaluation should differentiate vasculogenic ED from other causes.
  • Cardiovascular risk stratification for vasculogenic ED should utilize the 2013 ACC/AHA atherosclerotic CVD risk score.

Conclusions:

  • Clinicians should assess for ED in all men over 40, particularly those asymptomatic for CAD.
  • Cardiovascular risk stratification and risk factor reduction are recommended for all men with vasculogenic ED.
  • Prognostic markers, like coronary calcium scores, can enhance CV risk assessment in men with ED.